Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

NATUS MEDICAL INC (BABY)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Natus Medical : Natus to Present at the Thomas Weisel Partners 2007 Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/28/2007 | 02:00pm CET

Natus Medical Incorporated (Nasdaq:BABY) today announced that Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the Thomas Weisel Partners 2007 Healthcare Conference. The conference is being held at the Four Seasons Hotel in Boston, Massachusetts. Mr. Murphy is scheduled to present at 2:05 p.m. Eastern Time (11:05 a.m. PT) on Thursday, September 6, 2007.

Investors may listen to the live webcast and view a copy of the slide presentation online via the ?Investors? section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days. Attendance at the Thomas Weisel Partners 2007 Healthcare Conference is by invitation only.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, Chief Financial Officer, 650-802-0400
[email protected]


© Business Wire 2007
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
12/13 Natus to Present at J.P. Morgan 36th Annual Healthcare Conference
11/22 NATUS MEDICAL INC : Earnings Review and Free Research Report: Natus Medical’s Re..
11/17 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K Submission of Matters to..
11/17 NATUS MEDICAL INC : Submission of Matters to a Vote of Security Holders (form 8-..
11/09 Natus to Present at 29th Annual Piper Jaffray Healthcare Conference
11/06 NATUS MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
10/26 Natus to Present at Stifel 2017 Healthcare Conference
10/25 NATUS MEDICAL : reports 3Q loss
10/25 Natus Medical Announces Third Quarter 2017 Financial Results
10/25 NATUS MEDICAL INC : Results of Operations and Financial Condition, Financial Sta..
More news
News from SeekingAlpha
11/16 YOUR DAILY PHARMA SCOOP : A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tu..
11/16 Natus Medical (BABY) Presents At Stifel 2017 Healthcare Conference - Slidesho..
10/25 Natus Medical's (BABY) CEO Jim Hawkins on Q3 2017 Results - Earnings Call Tra..
10/25 Natus Medical beats by $0.02, beats on revenue
10/24 Notable earnings before Wednesday?s open
Financials ($)
Sales 2017 515 M
EBIT 2017 59,4 M
Net income 2017 4,67 M
Debt 2017 37 027 M
Yield 2017 -
P/E ratio 2017 395,50
P/E ratio 2018 26,45
Capi. / Sales 2017 74,2x
Capi. / Sales 2018 2,21x
Capitalization 1 232 M
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 55,0 $
Spread / Average Target 39%
EPS Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy Chief Financial Officer & Executive Vice President
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC8.91%1 218
THERMO FISHER SCIENTIFIC INC.33.21%75 586
DANAHER19.71%64 837
INTUITIVE SURGICAL81.55%41 855
ROYAL PHILIPS12.67%35 957
BOSTON SCIENTIFIC CORPORATION19.14%35 016